Bladder drug repurposed to fight ALS in new trial
Disease control
Recruiting now
This phase 2 trial tests whether darifenacin, a drug currently used for overactive bladder, can help people with ALS. The study will enroll 30 adults aged 18-85 with confirmed ALS. Participants will take either darifenacin or a placebo daily for 24 weeks. The goal is to see if th…
Phase: PHASE2 • Sponsor: Oliver Blanchard • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC